C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Objectives We aimed to examine whether the C-reactive protein (CRP) level could be used to differentiate between major depressive disorder (MDD) and bipolar II disorder (BD II). Methods Ninety-six healthy controls, 88 BD II and 72 MDD drug-naïve patients in their major depressive episodes were enrolled. The fasting plasma level of high-sensitivity CRP was assessed at baseline and after treatment. Results The BD II patients presented significantly higher 17-item Hamilton Depression Rating Scale (HDRS) scores and CRP levels at baseline when adjustment for age, gender, and body mass index (P < 0.001 and P < 0.001, respectively). After treatment the CRP levels remained significantly different (P < 0.001), although the HDRS score was not significantly different between the BD II and MDD patients. A receiver-operating characteristic analysis showed that a baseline CRP level of 621.6 ng/mL could discriminate between BD II and MDD, with an area under the curve of 0.816 and a sensitivity and specificity of 0.699 and 0.882, respectively. Furthermore, the baseline CRP level greater than 621.6 ng/ml had 28.2 higher odds of a diagnosis of BD II (P < 0.001, 95% confidence interval: 10.96-72.35). Conclusions The level of CRP plays a role of biomarker to differentiate between MDD and BD II depression in both their depressed and euthymic state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study proposed CRP as a biomarker to differentiate MDD and BD type 2 (BD-II), by recruiting 88 BD-II, 72 drug-naïve MDD and 96 healthy controls [79]. The authors found that a baseline CRP level of 621.6 ng/mL could discriminate between MDD and BD-II in both depressed and euthymic states [79].”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [79]
Citations
Cites
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 1×
“…Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, North Dist., Tainan 70403, Taiwan 2016 Informa UK Limited, trading as Taylor & Francis Group cardiovascular diseases and metabolic disturbances (Pearson et al. 2003; Nordestgaard and Zacho 2009; Wei et al. 2014).”
BackgroundROCR: visualizing classifier performance in R
Sing, T., Sander, O., Beerenwinkel, N., & Lengauer, T. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti623 · Cited by 3,200 · cited 1×
“Furthermore, the odds ratios were determined for all the cut-off points corresponding to the baseline CRP levels using R 2.13.1 software in the ROCR package (Sing et al. 2005).”
MethodInfluentialHodes, G. E., Pfau, M. L., Leboeuf, M., Golden, S. A., Christoffel, D. J., Bregman, D., Rebusi, N., Heshmati, M., Aleyasin, H., Warren, B. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415191111 · Cited by 692 · cited 1×
“Moreover, the higher level of CRP could be considered as evidence that link peripheral immune dysfunction to BD susceptibility in mood disorder patients (Anand et al. 2009; Hodes et al. 2014; Dargel et al. 2015; Harrison et al. 2015).”
BackgroundHantouche, E. G., Akiskal, H. S., Lancrenon, S., Allilaire, J.-F., Sechter, D., Azorin, J.-M., Bourgeois, M., Fraud, J.-P., & Châtenet-Duchêne, L. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00112-8 · Cited by 435 · cited 1×
“A systematic search found that 40% of major depressive episodes could be classified as BD II; however, only half of these were recognised by clinicians (Hantouche et al. 1998).”
BackgroundLeverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., Keck, P. E., Kupka, R. W., Denicoff, K. D., Nolen, W. A., Grunze, H., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.232 · Cited by 419 · cited 1×
“Moreover, compared with SSRI treatment, tricyclic antidepressant and SNRI treatment have been found to be related to a risk of induction of mood switch (Leverich et al. 2006; Amsterdam and Shults 2010).”
ResultCan bipolar disorder be viewed as a multi-system inflammatory disease?
Leboyer, M., Soreca, I., Scott, J., Frye, M., Henry, C., Tamouza, R., & Kupfer, D. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.049 · Cited by 417 · cited 1×
“It has been proposed that the pathophysiology of BD may not be limited to neurotransmitter abnormalities, but may reflect multifunctional system dysfunction, including the immune system (Leboyer et al. 2012; Rosenblat and McIntyre 2015).”
BackgroundAngst, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.87 · Cited by 417 · cited 1×
“At present, few phenotypes have been confirmed to differentiate BD II depression from unipolar depression (Angst et al. 2011).”
BackgroundAnand, A., Li, Y., Wang, Y., Lowe, M. J., & Dzemidzic, M. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.03.012 · Cited by 353 · cited 1×
“Moreover, the higher level of CRP could be considered as evidence that link peripheral immune dysfunction to BD susceptibility in mood disorder patients (Anand et al. 2009; Hodes et al. 2014; Dargel et al. 2015; Harrison et al. 2015).”
BackgroundVogelzangs, N., Duivis, H. E., Beekman, A. T. F., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J. H., de Jonge, P., & Penninx, B. W. J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.8 · Cited by 323 · cited 1×
“Adjunct medications with antiinflammatory activity might help to improve the treatment outcome and also reduce co-morbidity in BD II depression (Vogelzangs et al. 2012).”
BackgroundMansur, R. B., Brietzke, E., & McIntyre, R. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.017 · Cited by 322 · cited 1×
“Because patients with elevated inflammation are more likely to be obese and meet the criteria for metabolic syndrome, the difference in the CRP level might also be linked to the differing prevalence of metabolic syndrome among MDD, BD II and BD I patients (Mansur et al. 2015).”
BackgroundEstimation and Comparison of Receiver Operating Characteristic Curves
Pepe, M. S., Longton, G., & Janes, H. (2009) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0900900101 · Cited by 306 · cited 2×
“Since age and gender were significantly different between these two groups at baseline, covariateadjusted ROC curve, by age and gender, was determined by R 2.13.1 software using the pcvsuite package (Pepe et al. 2009).”
MethodInfluentialDifferential diagnosis of bipolar disorder and major depressive disorder
Hirschfeld, R. M. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70004-7 · Cited by 234
Bipolar disorder—focus on bipolar II disorder and mixed depression
Benazzi, F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60453-x · Cited by 231 · cited 1×
“Therefore, predictors of a poor treatment response in major depressive episodes might also be biomarkers for BD II depression (Benazzi 2007).”
BackgroundSubthreshold Hypomanic Symptoms in Progression From Unipolar Major Depression to Bipolar Disorder
Fiedorowicz, J. G., Endicott, J., Leon, A. C., Solomon, D. A., Keller, M. B., & Coryell, W. H. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030328 · Cited by 228 · cited 1×
“Sub-threshold manic symptoms have been linked to the progression to BD (Fiedorowicz et al. 2011).”
BackgroundLi, C.-T., Bai, Y.-M., Huang, Y.-L., Chen, Y.-S., Chen, T.-J., Cheng, J.-Y., & Su, T.-P. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.086983 · Cited by 177 · cited 1×
“In practise, a poor response to antidepressants could be a useful predictor of bipolar spectrum disorders (Li et al. 2012).”
BackgroundFond, G., Hamdani, N., Kapczinski, F., Boukouaci, W., Drancourt, N., Dargel, A., Oliveira, J., Le Guen, E., Marlinge, E., Tamouza, R., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12211 · Cited by 174 · cited 1×
“However, whether the anti-inflammatory effect of VPA is associated with its therapeutic effect in bipolar depression remains unclear, it has been shown that lithium has anti-inflammatory effects that may contribute to its therapeutic efficacy (Beurel and Jope 2014; Fond et al. 2014).”
BackgroundDickerson, F., Stallings, C. R., Origoni, A. E., Boronow, J. J., & Yolken, R. H. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.02.018 · Cited by 157 · cited 2×
“Importantly, the CRP level is significantly associated with sub-threshold manic symptoms in MDD patients (Dickerson et al. 2007; Becking et al. 2013).”
BackgroundC-Reactive Protein Alterations in Bipolar Disorder: A Meta-Analysis
Dargél, A. A., Godin, O., Kapczinski, F., Kupfer, D. J., & Leboyer, M. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14r09007 · Cited by 155 · cited 1×
“A meta-analysis study has reported that BD was associated with inflammation and that CRP could be a marker of mood state (Darg el et al. 2015; Wysokinski et al. 2015).”
BackgroundAmsterdam, J. D., & Shults, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020284 · Cited by 149 · cited 2×
“Moreover, compared with SSRI treatment, tricyclic antidepressant and SNRI treatment have been found to be related to a risk of induction of mood switch (Leverich et al. 2006; Amsterdam and Shults 2010).”
MethodResultAntidepressant therapy and C-reactive protein levels
O'Brien, S. M., Scott, L. V., & Dinan, T. G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.011015 · Cited by 148 · cited 1×
“In contrast to our results, one study with limited patients showed a significant drop in the CRP level after SSRI treatment in MDD patients (O’Brien et al. 2006).”
ResultBowden, C. L., Vieta, E., Ice, K. S., Schwartz, J. H., Wang, P. P., & Versavel, M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05482yel · Cited by 144
Contested boundaries of bipolar disorder and the limits of categorical diagnosis in psychiatry
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.11.1473 · Cited by 140
Vogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.9 · Cited by 133 · cited 1×
“Among the predictors of a poor treatment response, the level of C-reactive protein (CRP) has been found to be a differential predictor of the outcome of MDD (Vogelzangs et al. 2014).”
BackgroundBai, Y., Su, T., Tsai, S., Chiou, W., Li, C., Tu, P., & Mu-Hong, C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.009 · Cited by 131 · cited 1×
“In BD patients, peripheral immune markers have been found to be associated with mood status, metabolic status and cognitive function (Dickerson et al. 2013; Bai et al. 2014; Tsai et al. 2014).”
BackgroundElevated C-reactive protein and cognitive deficits in individuals with bipolar disorder
Dickerson, F., Stallings, C. R., Origoni, A. E., Vaughan, C., Khushalani, S., & Yolken, R. H. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.039 · Cited by 129 · cited 1×
“In BD patients, peripheral immune markers have been found to be associated with mood status, metabolic status and cognitive function (Dickerson et al. 2013; Bai et al. 2014; Tsai et al. 2014).”
BackgroundTreatment response and cognitive impairment in major depression: Association with C-reactive protein
Chang, H. H., Lee, I. H., Gean, P. W., Lee, S.-Y., Chi, M. H., Yang, Y. K., Lu, R.-B., & Chen, P. S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.239 · Cited by 120 · cited 2×
“The drug-na€ıve MDD patients enrolled were all meeting diagnostic criteria of MDD via the DSM-IV criteria at time of study entry and the HDRS scores> 15, as described before (Chang et al. 2012).”
BackgroundMethodSelf-citationLipids, atherosclerosis and CVD risk: Is CRP an innocent bystander?
Nordestgaard, B. G., & Zacho, J. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.07.005 · Cited by 101 · cited 1×
“…Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, North Dist., Tainan 70403, Taiwan 2016 Informa UK Limited, trading as Taylor & Francis Group cardiovascular diseases and metabolic disturbances (Pearson et al. 2003; Nordestgaard and Zacho 2009; Wei et al. 2014).”
BackgroundWatkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100 · cited 1×
“In addition, the antiinflammatory effect is achieved by histone deacetylase inhibition in glia and immune cells, which also play a key role in BD (Watkins et al. 2014).”
BackgroundAre medical comorbid conditions of bipolar disorder due to immune dysfunction?
Rosenblat, J. D., & McIntyre, R. S. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12414 · Cited by 97
Wysokiński, A., Margulska, A., Strzelecki, D., & Kłoszewska, I. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2014.984755 · Cited by 94 · cited 1×
“A meta-analysis study has reported that BD was associated with inflammation and that CRP could be a marker of mood state (Darg el et al. 2015; Wysokinski et al. 2015).”
BackgroundInflammation and lithium: clues to mechanisms contributing to suicide-linked traits
Beurel, E., & Jope, R. S. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.129 · Cited by 92
Huang, T.-L., & Lin, F.-C. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.010 · Cited by 90
Harrison, N. A., Cercignani, M., Voon, V., & Critchley, H. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.222 · Cited by 89 · cited 1×
“Moreover, the higher level of CRP could be considered as evidence that link peripheral immune dysfunction to BD susceptibility in mood disorder patients (Anand et al. 2009; Hodes et al. 2014; Dargel et al. 2015; Harrison et al. 2015).”
BackgroundDudek, D., Siwek, M., Zielińska, D., Jaeschke, R., & Rybakowski, J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.014 · Cited by 77 · cited 2×
“Whether a polarity switch would occur in certain MDD patients with a change in the CRP level remains to be investigated (Dudek et al. 2013).”
BackgroundValproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties
Ximenes, J. C. M., Gonçalves, D. D. O., Siqueira, R. M. P., Neves, K. R. T., Cerqueira, G. S., Correia, A. O., Felix, F. H. C., Leal, L. K. A. M., Brito, G. A. D. C., Naffah‐Mazzacoratti, M. D. G., et al. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0853-4 · Cited by 73 · cited 1×
“This indicated that the therapeutic effect of VPA might be correlated partially with its anti-inflammation action (Ximenes et al. 2013).”
BackgroundAnti-depressant medication use and C-reactive protein: Results from two population-based studies
Hamer, M., Batty, G., Marmot, M. G., Singh-Manoux, A., & Kivimäki, M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.013 · Cited by 71 · cited 1×
“Population-based studies also confirmed that the use of antidepressants, including SSRI and tricyclic antidepressants, is associated with a subsequently elevated CRP level independent of the symptoms of depression (Hamer et al. 2011).”
ResultThe association between immune activation and manic symptoms in patients with a depressive disorder
Becking, K., Boschloo, L., Vogelzangs, N., Haarman, B. C. M., Riemersma-van der Lek, R., Penninx, B. W. J. H., & Schoevers, R. A. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.87 · Cited by 71 · cited 3×
“the onset of manic symptoms in depressed patients during 2-year follow-up (Becking et al. 2013).”
BackgroundHalder, I., Marsland, A. L., Cheong, J., Muldoon, M. F., Ferrell, R. E., & Manuck, S. B. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.014 · Cited by 57 · cited 2×
“Moreover, the odds ratios for antidepressant use, hospitalisation and depression recurrence are significantly increased with increasing CRP levels (Halder et al. 2010).”
BackgroundPattern recognition analysis of anterior cingulate cortex blood flow to classify depression polarity
Almeida, J. R. C., Mourao-Miranda, J., Aizenstein, H. J., Versace, A., Kozel, F. A., Lu, H., Marquand, A., LaBarbara, E. J., Brammer, M., Trivedi, M., et al. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.122838 · Cited by 52 · cited 2×
“be shown to be integrated with genetic, molecular, neural circuitry and behavioural level biomarkers in BD using a dimensional approach to represent the underlying pathophysiological processes in BD (Almeida et al. 2013; Lee et al. 2013; Hirschfeld 2014).”
MethodMisdiagnosis of Bipolar Depression in Primary Care Practices
Culpepper, L. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13019tx1c · Cited by 44 · cited 1×
“Misdiagnosis of major depressive disorder (MDD) delays the initiation of appropriate therapy, leading to a poor outcome (Culpepper 2014).”
BackgroundFrankland, A., Cerrillo, E., Hadži-Pavlović, D., Roberts, G. M. P., Wright, A., Loo, C. K. A., Breakspear, M. J., & Mitchell, P. B. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09293 · Cited by 44 · cited 1×
“The number of prior episodes, feelings of worthlessness, age of onset, sleep patterns and mixed features could also help to distinguish between MDD and BD II depression (Frankland et al. 2015).”
BackgroundTsai, S., Chung, K., Huang, S., Chen, P., Lee, H., & Kuo, C. (2014) · Bipolar Disorders · doi:10.1111/bdi.12240 · Cited by 43 · cited 2×
“In BD patients, peripheral immune markers have been found to be associated with mood status, metabolic status and cognitive function (Dickerson et al. 2013; Bai et al. 2014; Tsai et al. 2014).”
BackgroundSelf-citationLee, S.-Y., Chen, S.-L., Chang, Y.-H., Chen, P. S., Huang, S.-Y., Tzeng, N.-S., Wang, Y.-S., Wang, L.-J., Lee, I. H., Wang, T.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066847 · Cited by 40
Self-citationDiagnosis, Treatment, and Recovery Maintenance in Bipolar Depression
Bowden, C. L. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.8125cc5c · Cited by 34
Chou, C. C., Lee, I. H., Yeh, T. L., Chen, K. C., Chen, P. S., Chen, W. T., Lu, R., & Yang, Y. K. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.644563 · Cited by 25 · cited 1×
“Previously, different versions of hypomanic checklists have been developed for the detection of hypomania in patients with mood disorders (Chou et al. 2012).”
BackgroundSelf-citationChi, M. H., Chang, H. H., Tzeng, N., Huang, S., Chou, K., Tsai, H. C., Yang, Y. K., Lu, R., & Chen, P. S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.042 · Cited by 20 · cited 1×
“Our previous studies have provided evidence to support this point (Hung Chi et al. 2013).”
ResultSelf-citationLövdahl, H., Bøen, E., Malt, E. A., & Malt, U. F. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.056 · Cited by 19 · cited 2×
“Among them, somatic and cognitive symptoms have been considered to be indicators of potential endophenotypes in bipolar spectrum disorders (Lovdahl et al. 2014).”
BackgroundDaigneault, A., Duclos, C., Saury, S., Paquet, J., Dumont, D., & Beaulieu, S. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.057 · Cited by 16 · cited 1×
“Bipolar II disorder (BD II) depression, a distinct category within mood disorders, is especially difficult to diagnose accurately (Daigneault et al. 2015).”
BackgroundCRP Gene polymorphism contributes genetic susceptibility to dyslipidemia in Han Chinese population
Wei, W., Yang, S., Qiu, Y., Wang, H., Zhao, X., Zhao, Y., Li, Y., Wu, M., Chen, Y., Wang, W., et al. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3087-8 · Cited by 8 · cited 1×
“…Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, North Dist., Tainan 70403, Taiwan 2016 Informa UK Limited, trading as Taylor & Francis Group cardiovascular diseases and metabolic disturbances (Pearson et al. 2003; Nordestgaard and Zacho 2009; Wei et al. 2014).”
Background
Cited by
Neuroinflammation in Bipolar Depression
Benedetti, F., Aggio, V., Pratesi, M. L., Greco, G., & Furlan, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00071 · Cited by 274
Fernandes, B. S., Steiner, J., Molendijk, M. L., Dodd, S., Nardin, P., Gonçalves, C.-A., Jacka, F., Köhler, C. A., Karmakar, C., Carvalho, A. F., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30370-4 · Cited by 247
Menzel, A., Samouda, H., Dohet, F., Loap, S., Ellulu, M. S., & Bohn, T. (2021) · Antioxidants · doi:10.3390/antiox10030414 · Cited by 217
“Recent work has further indicated that mental disorders, including bipolar disorder and chronic depression, are often linked with abnormalities in the immune system, including CRP [416].”
BackgroundSolmi, M., Suresh Sharma, M., Osimo, E. F., Fornaro, M., Bortolato, B., Croatto, G., Miola, A., Vieta, E., Pariante, C. M., Smith, L., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.014 · Cited by 196
C-Reactive protein as a biomarker for major depressive disorder?
Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171
“Moreover, CRP levels were strongly and positively associated with depression severity [81] Another study proposed CRP as a biomarker to differentiate MDD and BD type 2 (BD-II), by recruiting 88 BD-II, 72 drug-naïve MDD and 96 healthy controls [79].”
BackgroundInfluential
Metadata
- Authors
- Chang, H. H., Wang, T.-Y., Lee, I. H., Lee, S.-Y., Chen, K. C., Huang, S.-Y., Yang, Y. K., Lu, R.-B., & Chen, P. S.
- Affiliations
- National Cheng Kung University (TW)
- National Cheng Kung University Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- Tri-Service General Hospital (TW)
- Corresponding author
- Chen, Po See
- ORCID
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2016-04-20
- Volume
- 18
- Issue
- 1
- Pages
- 63-70
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2281714211
- Cited by
- 61
- References
- 49
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 9 · 2020: 1 · 2019: 5 · 2018: 4 · 2017: 1 · 2016: 4
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Council
- National Cheng Kung University Hospital
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- C-reactive protein, major depressive disorder, bipolar II disorder, differential diagnosis, inflammatory markers, high-sensitivity CRP, depression severity, euthymic state, antidepressant response
- MeSH terms
- Adult, Bipolar Disorder, C-Reactive Protein, Major Depressive Disorder, Female, Humans, Male, Middle Aged, ROC Curve, Sensitivity and Specificity, Taiwan, Biomarkers, Logistic Models, Case-Control Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.